ABSTRACT: QSAR analysis was performed using 20 MT1 agonist and 18 MT2 agonist. MODI was 0.6373 in case of Applicability domain were identified by Euclidean and Mahalanobis Distance Method. Finally it was clear that all the predicted data are inside the area of observed data points and also some data are purely overlapped.
INTRODUCTION
Presently barbiturates, benzodiazepines are being used as sedative hypnotics for the treatment of insomnia. However these drugs have side effects like high abuse potential, cognitive impairment, psychomotor impairment, dependence, tolerance, hangover, rebound insomnia, and so on. 1 A thirst for the discovery of newer hypnotics remains relevant till to date. Circadian rhythm is the term used to describe the physiological and behavioral twenty four hour cycle that most organisms experience. The mammalian biological clock is situated in the suprachiasmatic nucleus (SCN), which is located in the anterior hypothalamus. 2 After seeing relation between sleep and release of melatonin there has been a focus on the development of hypnotic agents 7-19, 2016 (June) that selectively target melatonin receptors. Melatonin (N-acetyl-5-methoxytryptamine), the hormone normally secreted from the pineal gland at night, serves as the signal of darkness in the organism and as such plays a pivotal role in the physiological regulation of circadian rhythms, including sleep. 3 Small number of melatonin receptor agonist like melatonin, ramelteon, tasimelteon, agomelatine are available in the market. Putative melatonin receptors are initially classified into MT1 and MT2, based on the kinetic and pharmacological differences in 2-[ 125 I] iodomelatonin binding. Melatonin is believed to exert these effects via two specific high affinity guanine nucleotide binding protein (G protein coupled receptors) in the SCN, MT1 and MT2. 4 Exogenous melatonin treatment has a phase shifting effect on circadian rhythms. The influence of an external agent on the biological clock is referred to as the chronobiotic effect. The chronobiotic effect of melatonin is due to the presence of MT1 and MT2 receptors in the SCN. MT1 receptors inhibit multiunit activity, while MT2 receptors are responsible for phase shifting responses. It seems likely from in vivo studies that the chronobiotic effect of exogenous melatonin is due to the concerted actions of MT2 resetting the circadian clock and MT1 suppressing neuronal firing at the SCN. Ramelteon has been shown to improve sleep disorders in patients suffering from transient and chronic insomnia without causing significant adverse events. In addition, Ramelteon has a low abuse potential and does not appear to be associated with a withdrawal syndrome or with rebound insomnia. Agomelatine received marketing authorization in the European Union in 2009, for the treatment of depression. In patients with major depression, agomelatine was similarly as effective as paroxetine, sertraline, venlafaxine and fluoxetine, with a lower relapse rate (23.9%) compared to the placebo (50.0%). Tasimelteon has been developed for the treatment of circadian rhythms sleep disorders and approved in the USA in 2014 for the treatment of non-24 h sleepwake disorder in the blind. 5 Moreover, it has been suggested that melatonin receptor agonists have opportunities to cure various diseases, like Alzheimer disease, bipolar disorder, cancer, hypertension, urinary incontinence, and so on.
In present study we have been develop a QSAR model for the future synthesis of melatonin receptor agonist using melatonin receptor agonist affinity data as biological activity.
MATERIALS AND METHODS
QSAR model was conducted by using a set of theoretical and constructive descriptors. QSAR Model was constructed by use of MLR Plus Validation Tool. More than 1800 descriptors include Ghose-Cripen Log Ko/w, Ghose-Crippen molar refractivity, Sum of the atomic polarizabilities (including implicit hydrogens), Wildman-Crippen LogP and MR, Wildman-Crippen MR, Eccentric Connectivity Index: topological descriptor combining distance and adjacency information, H Bond Acceptor Count Number of hydrogen bond acceptors, McGowan characteristic volume, Wiener Polarity Number, Kappa shape indices, Electrotopochemical atom were calculated by PADEL and ToMoCoMD software. All the explanations of relevant descriptors were enlisted in (Table 1) . A descriptor represents a quantitative property depends on the molecular structure. Theoretical descriptors were advantageous due to its free from uncertainty of experimental measurement and can be calculated for compounds before synthesis. Theoretical descriptors were employed in this QSAR study to model as melatonin (MT1 & MT2) receptor agonist. 
The chemometric tool. The development of QSAR equation was implemented two methods (1)
Stepwise regression (2) multiple linear regressions with factor analysis as pre processing factor analysis for variable selection (FA-MLR).
Stepwise regression. Multi step linear equation, a multistep equation was built by step by step. The basic procedure involved: (i) Identifying an initial model (ii) Repeating the previous step by altering descriptor or variable combination to achieve better F and r2 value. (iii) Calibrate the equation by justify the values in between observed and predicted values. The stepwise MLR was performed using statistical software SPSS and it was judged by parameters as explained variance (r 2 a), correlation coefficient (r), standard error of estimate (s) and variance ratio (F) at a specified degree of freedom (DF). All accepted MLR equation had regression level significant at 95 and 99% levels. The generated QSAR equation was validated by leave one out or LOO method using Minitab software and different parameters like cross validation r2 (q2), standard deviation based on press (S PRESS ) and standard deviation of error of prediction (SDEP).
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FA-MLR.
In this case a final statistical tool was used to develop a QSAR relation, factor analysis as a data pre processing step to identify the important factor to identify the important variables contributing the response variable by avoiding co linear value. The data matrix is first standardized and correlation matrix and subsequently reduced correlation matrix. An eigen value problem is then solved and the factor pattern can be obtained from the corresponding eigen vectors. The main objectives are to display multidimensional data in space of lower dimensionality with minimum loss of information (explaining > 95% of variance of data matrix) and to extract the basic features behind the data with ultimate goal of interpretation. 1. Q^2 value is passed (Threshold value Q^2>0.5).
2. r^2 value is passed (Threshold value r^2>0.6).
3. |r0^2-r'0^2| value is passed (Threshold value |r0^2-r'0^2|<0.3).
QSAR equation cross validation. The model was cross validated using Leave-One-Out (LOO) process. 32 Applicability domain of the developed QSAR equation was checked based on the response and chemical structure space in which the QSAR model makes predictions with a given reliability. Euclidean distance 33 and Mahalanobis 34 distance method. The distance of a test compound to its nearest neighbor in the training set is compared to the predefined applicability domain threshold.
MLR Y randomization test.
In this test, random MLR models were generated by randomly shuffling the dependent variable while keeping the independent variables as it is. The new QSAR models were expected to have significantly high R2 and Q2 values for several trials, which confirm that the developed QSAR models were robust. Another parameter, cRp2 was also calculated which should be more than 0.5 for passing this test. 
RESULTS AND DISCUSSION
The total dataset of 20 MTI receptor agonist and 18 MT2 receptor agonist were subdivided into training and test set along with chemical structure and pKd (affinity towards MT1 & MT2 receptor) as biological effect was diagrammatized in (Tables 2  and 3 ). The outcome from MODelability index was 0.6373 with threshold value 0.65 and total actives/toxic (H): 17.0000 total less actives/less toxic (L): 3.0000 in case of MT1 agonist and 0.6299 with threshold value 0.65 and total actives/toxic (H): 11.0000 total less actives/less toxic (L): 7.0000 in case of MT2 agonist and detail of MODelability Index was diagrammatized in (Table 4 ). In case of (Table 7) . The outcomes from applicability domain analysis by Euclidean and Mahalanobis distance methods are quite satisfactory within the normal distribution range and reported at (Tables 8-9 ). As per the Euclidean Distance method; in case of MT1 receptor agonist in the Training set, GR128107 and melaotnin molecule were with highest and lowest Euclidean distance score and in case of test set SD6 and UCM-793 were responsive for highest score and lowest Euclidean score respectively; and in case of MT2 receptor agonist in the training set; S26284 and Tasimelteon scored highest and lowest Euclidean distance and in case of test test; Lys15735 & 5-HEAT had lowest Euclidean distance. In case of Mahalanobis distance of MT1 receptor agonist, compound CBOBNEA with highest Mahalanobis distance of 3.12079 and melatonin with lowest Mahalanobis distance of 1.07321 among the training set compounds and compound SD6 with highest distance score of 2.04131 and ramelteon with 2.04121 lowest distance score among the test compounds as well as in case of MT2 receptor agonist compound S26284 and melatonin with highest and lowest mahalanobis distance respectively present inside the Training set and compound 5-HEAT and EFPPEA with highest and lowest mahalanobis distance respectively present inside the 18717 which also shown that the predictability of the model is quite high and the Y Randomization test result also shown that cRp^2: 0.7665 which must be greater than 0.5 for good predictability. In case of MT2 receptor agonist QSAR model: the difference between the r2 and r2adj value is 0.04135 which is less than 0.3 indicates that the number of descriptors involved in the QSAR model is acceptable and F test ratio value 22.43744 also reflects the greater predictability of the QSAR model. In the LOO result the difference between r2 and q2 (without scaling) is 0.01228 with accessible limit 0.3 which reflect the good predictability of the QSAR model. The rm^2(test) value for external validation is 0.70121 which must be greater than 0.5 as a good external predictability parameter. For a QSAR model can be considered acceptable if the values of r2m (overall) and r2p are equal to or above 0.5 (or at least near 0.5); in this developed QSAR model r2m is 0.70121 and r2p is 0.88118. 31 The results from Golbraikh and 0.7284 which must be greater than 0.5 for good predictability. As per the data from Applicability Domain analysis not a single molecule is outside the domain. Finally as per the overlapping data, it is quite clear that all the predicted data are inside the area of observed data points and also some data are purely overlapped.
